Agreement addresses all requests by President Trump to reduce drug costs in the U.S., encourage global investment and protect ...
Agreement with the U.S. government addresses prescription drug costs and encourages other wealthy nations to reward ...
Boards and executive buyers are raising the 2026 bar for all product and service rankings and this annual statement explains the standards Black Book applies to keep survey evaluations rigorous, ...
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a ...
The "Narcolepsy Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.Senior leaders in the narcolepsy treatment market face an industry defined by ...
The "Thyroid Eye Disease Treatments Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.The thyroid eye disease treatments market is undergoing substantial ...
Enlicitide has potential to be first approved oral PCSK9 inhibitor designed to help meet critical unmet needs for patients and will be offered at an affordable price to eligible Americans through a ...
Updated Fly-In Program outlines virtual consultations, travel timelines, recovery planning, and follow-up care for out-of-town patients visiting Tampa, Florida. TAMPA, FLORIDA / ACCESS Newswire / ...
The "In Silico Clinical Trials Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.The in silico clinical trials market is undergoing rapid transformation, ...
The "Von Willebrand Disease Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.Senior executives navigating the rare disease pharmaceutical sector ...
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that it has entered into a ...
Shareholders should contact the firm immediately as there may be limited time to enforce your rights.NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether ...